Globus Medical Inc (GMED) 24.85 $GMED
Globus Medical Schedules Fourth Quarter and Full Year 2014 Earnings Release and Conference Call
Business Wire - Wed Feb 11, 4:02PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and year ended December 31, 2014 after the market close on Wednesday, February 25, 2015. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 24.85 (+0.45)
U.S. Minimally Invasive Spinal Implant Market - 2015 Executive Summary
M2 - Fri Jan 09, 8:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/lkvb2c/u_s_minimally) has announced the addition of the "U.S. Minimally Invasive Spinal Implant Market - 2015 (Executive Summary)" report to their offering. Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to work. However, growth is expected to slow over the forecast period as a result of the increasing penetration of MIS procedures into the traditional fusion market and increases in the competing motion preservation market. The vast majority of patients, when given the option, will choose minimally invasive procedures rather than traditional open fusion surgeries. Patients are drawn to the advantages of less invasive techniques. MIS reduces muscle and tissue damage at the surgical site, decreases complications and limits intraoperative time. Clinical outcomes have been largely positive, further favoring the use of MIS techniques over open procedures. From a practice standpoint, more surgeons are looking into MIS approaches to not only market their practice competitively, but also to increase their potential revenues. MIS procedures often require less intraoperative and hospital time for the patient. As a result, surgeons would theoretically be able to perform more procedures within the same allotted amount of time than if they were to perform the procedures via an open approach. Key Topics Covered: - U.S. Minimally Invasive Spinal Implant Market - Spinous Process Fixation Market - Facet Fixation Market - Mis Interbody Fusion Market - Mis Pedicle Screw Market - Mis Sacroiliac Joint Fusion Market - Leading Competitors Companies Mentioned - Alphatec Spine - Amedica - Baxano Surgical - Biomet - DePuy Synthes - Globus Medical - Interventional Spine - K2M - Medtronic - NuVasive - Nutech - Orthofix - OsteoMed - Pioneer Surgical - SI-BONE - Stryker - VG Innovations - Zimmer - Zyga Technology For more information visit http://www.researchandmarkets.com/research/lk..._minimally
MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Spinal Products Firm NuVasive Ripe For Expansion
at Investor's Business Daily - Thu Jan 08, 2:17PM CST
Shares of NuVasive (NUVA) moved higher in early trading on the stock market today after the maker of spinal products received an analyst upgrade that cited its potential to grab more market share, particularly internationally. In a morning research...
LDRH: 37.73 (+1.70), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45), BAX: 70.39 (+0.31), COV: 106.71 (-1.36), EW: 134.23 (+1.89), NUVA: 46.99 (+0.30)
2015 U.S. Minimally Invasive Spinal Implant Market Report
M2 - Thu Jan 08, 10:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/dp4wpm/u_s_minimally) has announced the addition of the "U.S. Minimally Invasive Spinal Implant Market - 2015" report to their offering. The U.S. market for minimally invasive surgery (MIS) spinal implants includes spinous process fixation, facet fixation, MIS interbody fusion, MIS pedicle screws and MIS sacroiliac joint fusion. This U.S. Minimally Invasive Spinal Implant Market report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to work. However, growth is expected to slow over the forecast period as a result of the increasing penetration of MIS procedures into the traditional fusion market and increases in the competing motion preservation market. The vast majority of patients, when given the option, will choose minimally invasive procedures rather than traditional open fusion surgeries. Patients are drawn to the advantages of less invasive techniques. MIS reduces muscle and tissue damage at the surgical site, decreases complications and limits intraoperative time. Clinical outcomes have been largely positive, further favoring the use of MIS techniques over open procedures. From a practice standpoint, more surgeons are looking into MIS approaches to not only market their practice competitively, but also to increase their potential revenues. MIS procedures often require less intraoperative and hospital time for the patient. As a result, surgeons would theoretically be able to perform more procedures within the same allotted amount of time than if they were to perform the procedures via an open approach. Report Highlights: - Discusses changes to reimbursement policies among healthcare insurers will drastically change the market landscape - Recent introduction of spinous process fixation devices - Recent policy changes effecting the spinous process fixation market - Emerging technology in the minimally invasive surgery field - Pricing pressures driven by hospitals and insurance providers will effect the MIS Interbody Fusion Market - MIS Sacroiliac Joint Fusion Market change to a category I CPT code Companies Mentioned - Alphatec Spine - Amedica - Baxano Surgical - Biomet - DePuy Synthes - Globus Medical - Interventional Spine - K2M - Medtronic - NuVasive - Nutech - Orthofix - OsteoMed - Pioneer Surgical - SI-BONE - Stryker - VG Innovations - Zimmer - Zyga Technology For more information visit http://www.researchandmarkets.com/research/dp..._minimally
MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Globus Medical Announces Preliminary Q4 & 2014 Sales Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 4:35PM CST
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED) recently announced preliminary sales result for the fourth quarter and full-year 2014
ABMD: 60.39 (+0.46), GMED: 24.85 (+0.45), ANGO: 18.78 (+0.18), SURG: 4.44 (-0.02)
Globus Med sees Q4 sales up over 9%
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:19PM CST
GMED: 24.85 (+0.45)
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
Business Wire - Tue Jan 06, 3:05PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the year ending December 31, 2014, in advance of its annual national sales meeting being held later this week. The company anticipates fourth quarter 2014 sales of approximately $128.5 million, an 11.5% increase over fourth quarter 2013. Full year 2014 estimated sales increased to approximately $474 million or 9.1% over the prior year, exceeding the company's previous guidance range of $462-467 million.
GMED: 24.85 (+0.45)
Zynerba Pharmaceuticals Appoints Richard A. Baron VP and CFO
PR Newswire - Mon Jan 05, 6:30AM CST
Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, announced that the appointment of Richard A. Baron as vice president and chief financial officer (CFO) effective today. Mr. Baron offers more than 30 years of experience in executive finance leadership for early-stage, pharmaceutical and healthcare companies.
JNJ: 99.62 (+1.18), GMED: 24.85 (+0.45), LLY: 70.56 (+0.03)
Fluidigm (FLDM) Upgraded to Strong Buy on Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 11:40AM CST
On Dec 27, 2014, Zacks Investment Research upgraded Fluidigm Corporation (FLDM) to a Zacks Rank #1 (Strong Buy).
FLDM: 37.93 (-0.47), GMED: 24.85 (+0.45), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 4:55PM CST
Masimo Corporation's (MASI) ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform.
MASI: 27.38 (-0.21), GMED: 24.85 (+0.45), COV: 106.71 (-1.36), EW: 134.23 (+1.89)
North America Spinal Surgery Market - Industry Analysis And Market Forecast 2014-2020
M2 - Tue Dec 09, 8:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/w58zvn/north_america) has announced the addition of the "North America Spinal Surgery Market - Industry Analysis And Market Forecast 2014-2020" report to their offering. The North American market for Spinal Surgery is estimated to be valued as $7.76 billion for the year 2014 and is expected to reach $11.28 billion by the end of 2020. The CAGR during this period of forecast is 6.43%. Spinal surgical device market is a very significant and money-spinning sub section of orthopedic industry. Spine surgery is traditionally done as "open surgery," wherein a long incision allows the surgeon to access the spine anatomy. In the recent years, a minimally invasive surgical device technique has received increasing attention as it does not involve a long incision and hence causes minimal damage to the muscles around the spine. This results in lesser post-operative pain and faster recovery. Spinal surgeries can be classified as: - ALIF (Anterior Lumbar Interbody Fusion): for removal of a complete intervertebral disc. - Anterior Cervical Discectomy: to remove selected discs. - Bone Grafting: to place bone into an area of the spine in order to get solid bone healing (spinal fusion). - Discectomy: to remove a part or all of an intervertebral disc from the spine. - Spinal Decompression - Spinal Fusion - Spinal Instrumentation - Spinal Osteotomy - Thoracoscopic Release - TLIF The major players in this market are Globus Medical, Zimmer Holdings, Medtronic, Paradigm Spine, Stryker Corporation and Aplhatec Holdings. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. North American Spinal Surgery Market Segmentation 5. Competitive Landscape 6. Company Profiles For more information visit http://www.researchandmarkets.com/research/w5...th_america
ZMH: 119.33 (+1.18), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45), SYK: 94.51 (+1.14)
Globus Medical: Best Positioned Play In The Spine Recovery Market
Value Wagon - at Seeking Alpha - Thu Nov 20, 8:26AM CST
GMED: 24.85 (+0.45)
Exactech's Equinoxe Shoulder System: 10 Years of Success - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:55PM CST
Developer of orthopedic implant devices Exactech Inc. (EXAC) recently announced the 10th year anniversary of its Equinoxe Shoulder System, a product line in its shoulder business.
ZMH: 119.33 (+1.18), GMED: 24.85 (+0.45), EXAC: 22.33 (-0.28), SYK: 94.51 (+1.14)
Exactech's (EXAC) Octane Elevate to Advance Spine Surgery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:15PM CST
Developer of orthopedic implant devices, Exactech Inc. (EXAC), recently announced the launch of Octane Elevate, a self-distracting lumber fusion device made of Poly Ether Ether Ketone (PEEK), a colorless organic thermoplastic polymer.
ZMH: 119.33 (+1.18), GMED: 24.85 (+0.45), EXAC: 22.33 (-0.28), SYK: 94.51 (+1.14)
Globus Medical to Redefine Spinal Fusion with ALTERA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:07PM CST
Manufacturer of musculoskeletal implants, Globus Medical Inc. (GMED), recently announced the launch of ALTERA, which is claimed to be the first minimally intrusive expandable spacer.
ZMH: 119.33 (+1.18), GMED: 24.85 (+0.45), EXAC: 22.33 (-0.28), SYK: 94.51 (+1.14)
Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), GMED: 24.85 (+0.45), ANGO: 18.78 (+0.18)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 35.82 (-0.28), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 35.82 (-0.28), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Globus Medical Announces ALTERA(TM) Minimally Invasive Articulating Expandable Spacer
Business Wire - Tue Nov 11, 11:38PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, and the worldwide leader in expandable interbody technology, today announced the launch of ALTERA(TM), the first new minimally invasive fully articulating expandable spacer for spinal fusion. Designed for restoring lordosis and maintaining sagittal balance while reducing the challenges of insertion, the spacer is inserted at a minimized height, articulated into an anterior position, and then expanded vertically to optimize fit. The company is showcasing ALTERA(TM) as well as several recently launched products at the North American Spine Society (NASS) Annual Meeting, being held in San Francisco this week, Booth #1119.
GMED: 24.85 (+0.45), ALTR: 35.66 (+0.45)
NYSE stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
RATE: 12.49 (+0.27), RAX: 50.01 (+0.24), PVG.TO: 8.06 (-0.05), PVG: 6.44 (-0.07), THO.TO: 16.73 (+0.44), ZTS: 45.46 (-0.33), W: 21.96 (-1.01), GLP: 38.13 (-0.44), GMED: 24.85 (+0.45), EGO: 4.94 (+0.10), DWRE: 55.99 (+0.45), PLOW: 21.90 (+0.32), ELD.TO: 6.15 (+0.09), DF: 16.19 (-0.11), TAHO: 13.42 (+0.38)
Globus Medical Schedules Fourth Quarter and Full Year 2014 Earnings Release and Conference Call
Business Wire - Wed Feb 11, 4:02PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the fourth quarter and year ended December 31, 2014 after the market close on Wednesday, February 25, 2015. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 24.85 (+0.45)
U.S. Minimally Invasive Spinal Implant Market - 2015 Executive Summary
M2 - Fri Jan 09, 8:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/lkvb2c/u_s_minimally) has announced the addition of the "U.S. Minimally Invasive Spinal Implant Market - 2015 (Executive Summary)" report to their offering. Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to work. However, growth is expected to slow over the forecast period as a result of the increasing penetration of MIS procedures into the traditional fusion market and increases in the competing motion preservation market. The vast majority of patients, when given the option, will choose minimally invasive procedures rather than traditional open fusion surgeries. Patients are drawn to the advantages of less invasive techniques. MIS reduces muscle and tissue damage at the surgical site, decreases complications and limits intraoperative time. Clinical outcomes have been largely positive, further favoring the use of MIS techniques over open procedures. From a practice standpoint, more surgeons are looking into MIS approaches to not only market their practice competitively, but also to increase their potential revenues. MIS procedures often require less intraoperative and hospital time for the patient. As a result, surgeons would theoretically be able to perform more procedures within the same allotted amount of time than if they were to perform the procedures via an open approach. Key Topics Covered: - U.S. Minimally Invasive Spinal Implant Market - Spinous Process Fixation Market - Facet Fixation Market - Mis Interbody Fusion Market - Mis Pedicle Screw Market - Mis Sacroiliac Joint Fusion Market - Leading Competitors Companies Mentioned - Alphatec Spine - Amedica - Baxano Surgical - Biomet - DePuy Synthes - Globus Medical - Interventional Spine - K2M - Medtronic - NuVasive - Nutech - Orthofix - OsteoMed - Pioneer Surgical - SI-BONE - Stryker - VG Innovations - Zimmer - Zyga Technology For more information visit http://www.researchandmarkets.com/research/lk..._minimally
MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Spinal Products Firm NuVasive Ripe For Expansion
at Investor's Business Daily - Thu Jan 08, 2:17PM CST
Shares of NuVasive (NUVA) moved higher in early trading on the stock market today after the maker of spinal products received an analyst upgrade that cited its potential to grab more market share, particularly internationally. In a morning research...
LDRH: 37.73 (+1.70), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45), BAX: 70.39 (+0.31), COV: 106.71 (-1.36), EW: 134.23 (+1.89), NUVA: 46.99 (+0.30)
2015 U.S. Minimally Invasive Spinal Implant Market Report
M2 - Thu Jan 08, 10:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/dp4wpm/u_s_minimally) has announced the addition of the "U.S. Minimally Invasive Spinal Implant Market - 2015" report to their offering. The U.S. market for minimally invasive surgery (MIS) spinal implants includes spinous process fixation, facet fixation, MIS interbody fusion, MIS pedicle screws and MIS sacroiliac joint fusion. This U.S. Minimally Invasive Spinal Implant Market report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to work. However, growth is expected to slow over the forecast period as a result of the increasing penetration of MIS procedures into the traditional fusion market and increases in the competing motion preservation market. The vast majority of patients, when given the option, will choose minimally invasive procedures rather than traditional open fusion surgeries. Patients are drawn to the advantages of less invasive techniques. MIS reduces muscle and tissue damage at the surgical site, decreases complications and limits intraoperative time. Clinical outcomes have been largely positive, further favoring the use of MIS techniques over open procedures. From a practice standpoint, more surgeons are looking into MIS approaches to not only market their practice competitively, but also to increase their potential revenues. MIS procedures often require less intraoperative and hospital time for the patient. As a result, surgeons would theoretically be able to perform more procedures within the same allotted amount of time than if they were to perform the procedures via an open approach. Report Highlights: - Discusses changes to reimbursement policies among healthcare insurers will drastically change the market landscape - Recent introduction of spinous process fixation devices - Recent policy changes effecting the spinous process fixation market - Emerging technology in the minimally invasive surgery field - Pricing pressures driven by hospitals and insurance providers will effect the MIS Interbody Fusion Market - MIS Sacroiliac Joint Fusion Market change to a category I CPT code Companies Mentioned - Alphatec Spine - Amedica - Baxano Surgical - Biomet - DePuy Synthes - Globus Medical - Interventional Spine - K2M - Medtronic - NuVasive - Nutech - Orthofix - OsteoMed - Pioneer Surgical - SI-BONE - Stryker - VG Innovations - Zimmer - Zyga Technology For more information visit http://www.researchandmarkets.com/research/dp..._minimally
MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Globus Medical Announces Preliminary Q4 & 2014 Sales Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 4:35PM CST
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED) recently announced preliminary sales result for the fourth quarter and full-year 2014
ABMD: 60.39 (+0.46), GMED: 24.85 (+0.45), ANGO: 18.78 (+0.18), SURG: 4.44 (-0.02)
Globus Med sees Q4 sales up over 9%
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:19PM CST
GMED: 24.85 (+0.45)
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results
Business Wire - Tue Jan 06, 3:05PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced preliminary unaudited sales results for the year ending December 31, 2014, in advance of its annual national sales meeting being held later this week. The company anticipates fourth quarter 2014 sales of approximately $128.5 million, an 11.5% increase over fourth quarter 2013. Full year 2014 estimated sales increased to approximately $474 million or 9.1% over the prior year, exceeding the company's previous guidance range of $462-467 million.
GMED: 24.85 (+0.45)
Zynerba Pharmaceuticals Appoints Richard A. Baron VP and CFO
PR Newswire - Mon Jan 05, 6:30AM CST
Zynerba Pharmaceuticals, Inc., a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, announced that the appointment of Richard A. Baron as vice president and chief financial officer (CFO) effective today. Mr. Baron offers more than 30 years of experience in executive finance leadership for early-stage, pharmaceutical and healthcare companies.
JNJ: 99.62 (+1.18), GMED: 24.85 (+0.45), LLY: 70.56 (+0.03)
Fluidigm (FLDM) Upgraded to Strong Buy on Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 11:40AM CST
On Dec 27, 2014, Zacks Investment Research upgraded Fluidigm Corporation (FLDM) to a Zacks Rank #1 (Strong Buy).
FLDM: 37.93 (-0.47), GMED: 24.85 (+0.45), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Masimo's Multigas Monitoring Module Gets 510(k), CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 4:55PM CST
Masimo Corporation's (MASI) ISA OR+ multigas monitoring is a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform.
MASI: 27.38 (-0.21), GMED: 24.85 (+0.45), COV: 106.71 (-1.36), EW: 134.23 (+1.89)
North America Spinal Surgery Market - Industry Analysis And Market Forecast 2014-2020
M2 - Tue Dec 09, 8:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/w58zvn/north_america) has announced the addition of the "North America Spinal Surgery Market - Industry Analysis And Market Forecast 2014-2020" report to their offering. The North American market for Spinal Surgery is estimated to be valued as $7.76 billion for the year 2014 and is expected to reach $11.28 billion by the end of 2020. The CAGR during this period of forecast is 6.43%. Spinal surgical device market is a very significant and money-spinning sub section of orthopedic industry. Spine surgery is traditionally done as "open surgery," wherein a long incision allows the surgeon to access the spine anatomy. In the recent years, a minimally invasive surgical device technique has received increasing attention as it does not involve a long incision and hence causes minimal damage to the muscles around the spine. This results in lesser post-operative pain and faster recovery. Spinal surgeries can be classified as: - ALIF (Anterior Lumbar Interbody Fusion): for removal of a complete intervertebral disc. - Anterior Cervical Discectomy: to remove selected discs. - Bone Grafting: to place bone into an area of the spine in order to get solid bone healing (spinal fusion). - Discectomy: to remove a part or all of an intervertebral disc from the spine. - Spinal Decompression - Spinal Fusion - Spinal Instrumentation - Spinal Osteotomy - Thoracoscopic Release - TLIF The major players in this market are Globus Medical, Zimmer Holdings, Medtronic, Paradigm Spine, Stryker Corporation and Aplhatec Holdings. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. North American Spinal Surgery Market Segmentation 5. Competitive Landscape 6. Company Profiles For more information visit http://www.researchandmarkets.com/research/w5...th_america
ZMH: 119.33 (+1.18), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45), SYK: 94.51 (+1.14)
Globus Medical: Best Positioned Play In The Spine Recovery Market
Value Wagon - at Seeking Alpha - Thu Nov 20, 8:26AM CST
GMED: 24.85 (+0.45)
Exactech's Equinoxe Shoulder System: 10 Years of Success - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:55PM CST
Developer of orthopedic implant devices Exactech Inc. (EXAC) recently announced the 10th year anniversary of its Equinoxe Shoulder System, a product line in its shoulder business.
ZMH: 119.33 (+1.18), GMED: 24.85 (+0.45), EXAC: 22.33 (-0.28), SYK: 94.51 (+1.14)
Exactech's (EXAC) Octane Elevate to Advance Spine Surgery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:15PM CST
Developer of orthopedic implant devices, Exactech Inc. (EXAC), recently announced the launch of Octane Elevate, a self-distracting lumber fusion device made of Poly Ether Ether Ketone (PEEK), a colorless organic thermoplastic polymer.
ZMH: 119.33 (+1.18), GMED: 24.85 (+0.45), EXAC: 22.33 (-0.28), SYK: 94.51 (+1.14)
Globus Medical to Redefine Spinal Fusion with ALTERA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:07PM CST
Manufacturer of musculoskeletal implants, Globus Medical Inc. (GMED), recently announced the launch of ALTERA, which is claimed to be the first minimally intrusive expandable spacer.
ZMH: 119.33 (+1.18), GMED: 24.85 (+0.45), EXAC: 22.33 (-0.28), SYK: 94.51 (+1.14)
Abiomed (ABMD) Hits 52-Week High on Strong Q2 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 10:10AM CST
Shares of Abiomed, Inc. (ABMD) have been on the rise since it reported impressive second-quarter fiscal 2015 (ended Sep 30, 2014) results on Oct 30.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), GMED: 24.85 (+0.45), ANGO: 18.78 (+0.18)
Global Orthopedic Implant Physician Preference Survey 2015 - Executive Summary
M2 - Wed Nov 12, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/wkgmtc/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015 (Executive Summary)" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Key Topics Covered: - Survey Background - Survey Respondent Profile - Knee Repair Products - Foot Digit Repair Products - Hip Repair Products - Hand Digit Repair Products - Spinal Surgery Products - Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/wk...orthopedic
SNN: 35.82 (-0.28), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Global Orthopedic Implant Physician Preference Survey 2015
M2 - Wed Nov 12, 9:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/9rfcq6/global_orthopedic) has announced the addition of the "Global Orthopedic Implant Physician Preference Survey 2015" report to their offering. This survey asked physicians to choose the company or companies that provide knee repair products with which they are most satisfied. More than one-third of respondents who do knee repair surgeries included DePuy Synthes as one of their preferred companies. This was followed closely by other competitors such as MAKO Surgical, Smith & Nephew, Stryker and Zimmer. The survey also asked physicians to suggest what factor or factors would most likely trigger them to switch over to using a different knee repair product from that which they were currently most comfortable. While many surgeons suggested multiple factors, one that appeared most frequently was if another product was able to demonstrate better clinical efficacy in comparison to the current product in use. This trend was present from respondents across all geographical regions and clinical settings. Despite subtle differences in physician product preference across the various regions, the survey results suggest that DePuy Synthes is the most highly preferred supplier of knee repair products globally. Survey includes: - Patient Volumes - Procedures Performed - Clinical Setting - Product prerference by manufacturer - Factors influencing produt change - Preferences by region, country and clinical setting Key Topics Covered: 1. Executive Summary 2. Research Methodology And Survey Coverage 3. Survey Respondent Profile 4. Osteoarthritis Treatment Preferences 5. Product Preference Overview 6. Knee Repair Products 7. Hip Repair Products 8. Hand Digit Repair Products 9. Foot Digit Repair Products 10. Cervical Interbody Products 11. Thoracolumbar Interbody Products 12. Custom Implants Companies Mentioned - Aesculap - Alphatec Spine - Arthrex - BioPro - Biomet - DJO Surgical - DePuy Synthes - Exactech - Globus Medical - Integra LifeSciences - K2M - MAKO Surgical - Medtronic - NuVasive - Small Bone Innovations (SBi) - Smith & Nephew - Stryker - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/9r...orthopedic
SNN: 35.82 (-0.28), MDT: 75.26 (+0.33), GMED: 24.85 (+0.45)
Globus Medical Announces ALTERA(TM) Minimally Invasive Articulating Expandable Spacer
Business Wire - Tue Nov 11, 11:38PM CST
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, and the worldwide leader in expandable interbody technology, today announced the launch of ALTERA(TM), the first new minimally invasive fully articulating expandable spacer for spinal fusion. Designed for restoring lordosis and maintaining sagittal balance while reducing the challenges of insertion, the spacer is inserted at a minimized height, articulated into an anterior position, and then expanded vertically to optimize fit. The company is showcasing ALTERA(TM) as well as several recently launched products at the North American Spine Society (NASS) Annual Meeting, being held in San Francisco this week, Booth #1119.
GMED: 24.85 (+0.45), ALTR: 35.66 (+0.45)
NYSE stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
RATE: 12.49 (+0.27), RAX: 50.01 (+0.24), PVG.TO: 8.06 (-0.05), PVG: 6.44 (-0.07), THO.TO: 16.73 (+0.44), ZTS: 45.46 (-0.33), W: 21.96 (-1.01), GLP: 38.13 (-0.44), GMED: 24.85 (+0.45), EGO: 4.94 (+0.10), DWRE: 55.99 (+0.45), PLOW: 21.90 (+0.32), ELD.TO: 6.15 (+0.09), DF: 16.19 (-0.11), TAHO: 13.42 (+0.38)
